EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Underlying Genetics of aHUS: Which Connection with Outcome and Treatment Discontinuation?

Andrea Spasiano iD, Daniela Palazzetti, Lucrezia Dimartino, Francesca Bruno, Rocco Baccaro, Francesco Pesce, Giuseppe Grandaliano

International Journal of Molecular Sciences · 2023

DOI: 10.3390/ijms241914496 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Andrea Spasiano und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Translational Medicine and Surgery, Università Cattolica del Sacro Cuore, 00168 Rome, Italy. Hauptthemen laut MEDLINE: Atypical Hemolytic Uremic Syndrome, Thrombotic Microangiopathies, Kidney Failure, Chronic, Acute Kidney Injury. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Atypical hemolytic uremic syndrome (aHUS) is a rare disease caused by a genetic dysregulation of the alternative complement pathway, characterized by thrombocytopenia, hemolytic anemia, and acute kidney injury, and included in the group of thrombotic microangiopathies. With the introduction of humanized monoclonal antibodies that inhibit C5 activation, the natural history of aHUS completely changed, with a better prognosis, a quick recovery of renal function, and a significant reduction of end-stage renal disease incidence. Nowadays, there is an increasing interest in the molecular and genetic bases of this severe disease. The aim of this narrative review is to provide readers with a practical guide about different possible involved genes, elucidating the specific role of each transcribed protein in the pathogenesis of aHUS. Moreover, we analyzed the main current evidence about the relationship among genetic mutations, outcomes, and the risk of recurrence of this manifold disease.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Atypical Hemolytic Uremic SyndromeThrombotic MicroangiopathiesKidney Failure, ChronicAcute Kidney InjuryHumansMutation

Stichwörter der Autor:innen

CFHMCPaHUSatypical hemolytic uremic syndromegenetics

Autor:innen und Institutionen

  • Department of Translational Medicine and Surgery, Università Cattolica del Sacro Cuore, 00168 Rome, Italy.
  • Nephrology Unit, Department of Medical and Surgical Sciences, Fondazione Policlinico Universitario A. Gemelli, 00168 Rome, Italy.
  • Division of Renal Medicine, Fatebenefratelli Isola Tiberina-Gemelli Isola, 00186 Rome, Italy.

ORCID-Profile: Andrea Spasiano

Zitieren

APA

Spasiano, A., Palazzetti, D., Dimartino, L., Bruno, F., Baccaro, R., Pesce, F., & Grandaliano, G. (2023). Underlying Genetics of aHUS: Which Connection with Outcome and Treatment Discontinuation?. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms241914496

Vancouver

Spasiano A, Palazzetti D, Dimartino L, Bruno F, Baccaro R, Pesce F, et al. Underlying Genetics of aHUS: Which Connection with Outcome and Treatment Discontinuation?. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms241914496

BibTeX
@article{Spasiano2023,
  author = {Spasiano, Andrea and Palazzetti, Daniela and Dimartino, Lucrezia and Bruno, Francesca and Baccaro, Rocco and Pesce, Francesco and Grandaliano, Giuseppe},
  title = {Underlying Genetics of aHUS: Which Connection with Outcome and Treatment Discontinuation?},
  journal = {International Journal of Molecular Sciences},
  year = {2023},
  doi = {10.3390/ijms241914496}
}
Kostenlos starten →